Cargando…
Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates: Revolutions in treatment options in GIST
The treatment of advanced GIST is rapidly evolving with the development of novel molecular compounds such as avapritinib and ripretinib, but also promising results have been achieved with cabozantinib in a phase II trial. The availability of over five lines of treatment for patients with advanced GI...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253383/ https://www.ncbi.nlm.nih.gov/pubmed/32462367 http://dx.doi.org/10.1007/s11864-020-00754-8 |